Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
86.53
+0.32 (0.37%)
Dec 20, 2024, 4:00 PM EST - Market closed
Vaxcyte Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 10,785 | 5,976 | 3,787 | 1,256 | 1,354 | - | |
| Market Cap Growth | 195.44% | 57.79% | 201.58% | -7.24% | - | - | |
| Enterprise Value | 8,632 | 4,724 | 3,445 | 978 | 957 | - | |
| Last Close Price | 86.53 | 62.80 | 47.95 | 23.79 | 26.57 | - | |
| PB Ratio | 3.15 | 4.82 | 3.97 | 4.42 | 3.91 | - | |
| P/TBV Ratio | 4.14 | 4.82 | 3.97 | 4.42 | 3.91 | - | |
| Debt / Equity Ratio | 0.01 | 0.02 | 0.02 | 0.06 | - | 0.00 | |
| Quick Ratio | 17.76 | 7.46 | 23.08 | 8.61 | 8.25 | 5.35 | |
| Current Ratio | 17.88 | 7.54 | 23.26 | 8.93 | 8.30 | 5.58 | |
| Return on Equity (ROE) | -21.06% | -36.67% | -36.11% | -31.78% | -44.58% | -87.49% | |
| Return on Assets (ROA) | -14.93% | -24.23% | -21.82% | -18.07% | -24.42% | -49.59% | |
| Return on Capital (ROIC) | -15.53% | -26.10% | -22.82% | -20.04% | -27.97% | -57.01% | |
| Earnings Yield | -4.71% | -6.73% | -5.90% | -7.97% | -6.59% | - | |
| FCF Yield | -5.71% | -6.10% | -4.66% | -10.19% | -3.53% | - | |
| Buyback Yield / Dilution | -24.70% | -49.75% | -24.95% | -75.73% | -678.53% | -4.55% | |
| Total Shareholder Return | -24.70% | -49.75% | -24.95% | -75.73% | -678.53% | -4.55% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.